Skip to main content
AAO-HNSF 2026 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Matthew J. Mifsud, MD

Associate Professor &Interim Chair, Chief Division of Head & Neck Oncology & Reconstructive Surgery
University of South Florida Department of Otolaryngology - Head and Neck Surgery
Tampa, Florida, United States

Dr. Matthew Mifsud MD FACS is Vice Chairman of the University of South Florida Department of Otolaryngology Head & Neck Surgery and Chief of the Division of Head & Neck Oncology and Microvascular Reconstructive Surgery. He is also a past president of the Florida Society of Otolaryngology Head & Neck Surgery. Under his leadership, the Head & Neck Microvascular Program at USF and its clinical partner, Tampa General Hospital (TGH), has grown into a regional and national center of excellence.

Dr. Mifsud’s clinical philosophy emphasizes innovative, multidisciplinary, patient-centered care. The microvascular surgical program he leads incorporates an enhanced recovery after anesthesia (ERAS©) model, which reduces ICU stays and accelerates recovery. He is also the founding member of the USF Center for Advanced Salivary Gland Surgery—the first of its kind in Florida—providing comprehensive care for salivary gland conditions, from inflammatory disorders to malignancies.

In addition to his clinical leadership, Dr. Mifsud is a dedicated researcher with contributions in epidemiology, treatment outcomes, and novel therapies for head and neck cancers. He is deeply committed to improving long-term survivorship and quality of life for cancer patients. At USF, he founded a multidisciplinary research consortium focused on advancing care through collaborative investigation

Presentation(s):

Email Matthew